Copyright
©The Author(s) 2015.
World J Gastroenterol. Jan 14, 2015; 21(2): 563-570
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.563
Published online Jan 14, 2015. doi: 10.3748/wjg.v21.i2.563
Figure 2 Recurrence-free survival of patients with yp Stage III disease treated with different adjuvant chemotherapy regimens.
Patients with yp Stage III that received a different second-line chemotherapy regimen had longer recurrence-free survival than patients receiving a regimen that was the same as the preoperative concurrent regimen.
- Citation: Hwang K, Park IJ, Yu CS, Lim SB, Lee JL, Yoon YS, Kim CW, Kim JC. Impression of prognosis regarding pathologic stage after preoperative chemoradiotherapy in rectal cancer. World J Gastroenterol 2015; 21(2): 563-570
- URL: https://www.wjgnet.com/1007-9327/full/v21/i2/563.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i2.563